Actively Recruiting
Observational Study on Diffuse Midline Glioma and Diffuse Intrinsic Pontine Glioma Collecting Patient Data and Outcomes Nationwide
Led by xCures · Updated on 2024-04-30
400
Participants Needed
1
Research Sites
17 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are conducting a nationwide, fully virtual observational study to collect detailed information on diffuse midline glioma DMG, including diffuse intrinsic pontine glioma DIPG. The study aims to establish a clear natural history of these diseases by gathering data from both new and existing patients. This information will serve as an external control for future drug, device, or biologic therapy development programs. The study operates under a regulatory-compliant framework and is part of the broader XCELSIOR protocol.
CONDITIONS
Brief Title
xPedite: A Study to Expedite DIPG and DMG Research
Research Team
X
xCures Study Team
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
